M&A Deal Summary

SOBI Acquires Swedish Orphan International

On November 5, 2009, SOBI acquired healthcare services company Swedish Orphan International from Priveq for 3.5B SEK

Acquisition Highlights
  • This is SOBI’s 1st transaction in the Healthcare Services sector.
  • This is SOBI’s 3rd largest (disclosed) transaction.
  • This is SOBI’s 1st transaction in Sweden.

M&A Deal Summary

Date 2009-11-05
Target Swedish Orphan International
Sector Healthcare Services
Buyer(s) SOBI
Sellers(s) Priveq
Deal Type Add-on Acquisition
Deal Value 3.5B SEK

Target

Swedish Orphan International

Sweden
Swedish Orphan International engages in the research, development, production, distribution, and marketing of specialty pharmaceuticals.

Search 191,543 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

SOBI

Stockholm 

, Sweden

website


Category Company
Sector Life Science
Employees1,537
Revenue 15.3B SEK (2020)
DESCRIPTION

SOBI a integrated biopharmaceutical company with international market presence, developing and commercializing pharmaceuticals for patients with rare diseases.


DEAL STATS #
Overall 2 of 4
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 2 of 4
Country (Sweden) 1 of 1
Year (2009) 1 of 1
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-03-21 Cambridge Biotechnology

Cambridge, United Kingdom

Cambridge Biotechnology Ltd. is a Cambridge UK based private drug discovery company. CBT's drug discovery efforts have been focused on obesity, pain and inflammation, utilizing the company's top class scientific and technical skills in the field of cytokine receptors.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-30 Dova Pharmaceuticals

Durham, North Carolina, United States

Dova Pharmaceuticals, Inc. is a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases where there is a high unmet medical need. Dova Pharmaceuticals was founded in 2016 and is headquartered in Durham, North Carolina.

Buy $915M

Seller(S) 1

SELLER

Priveq

Stockholm, Sweden

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1983
PE ASSETS 6.3B SEK
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Priveq is a private equity firm that invests in privately owned, small and medium-sized Scandinavian companies. Priveq targets profitable businesses with strong market positions and growth potential. The Firm looks to invest SEK 5 – 200 million in companies with sales typically greater than SEK 100 million. Priveq generally seeks equity between 30 and 70 percent in portfolio companies. The Firm will invest in a wide range of industries, but avoids real estate. Prospective transaction types include MBOs and growth capital financings. Priveq Investment was formerly known as Skandia Investment AB. The Firm was formed in 1983 and is based in Stockholm.


DEAL STATS #
Overall 6 of 31
Sector (Healthcare Services) 2 of 4
Type (Add-on Acquisition) 3 of 12
Country (Sweden) 6 of 28
Year (2009) 1 of 1
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-05-07 Carmel Pharma AB

Molndal, Sweden

Carmel Pharma ab engages in the manufacture and distribution of products that improve the quality of life of people who prepare, administer, and dispose of hazardous drugs. It offers the PhaSeal System, a closed-system drug transfer device that prevents hazardous drug interaction with the environment.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-11-09 Vårdapoteket i Norden AB

Malmo, Sweden

As part of the Swedish Government sell-off of its former pharmacy monopoly, Priveq Investment and Investor Growth Capital are acquiring the pharmacies in clusters 6 and 7 offered by Apoteket Omstrukturering AB through newly incorporated entity Vårdapoteket i Norden AB. The operation consists of 24 outpatient dispensing pharmacies located on-site in hospitals, concentrated in central and southern Sweden. Vårdapoteket i Norden AB will have sales of over SEK 1,400 m and some 250 employees with solid pharmaceutical skills and backgrounds.

Buy -